Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | LPL | P06858 | 2/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2171752 | 0.81 | CA2 (0.71) | CA2CA4CA5ATSHR | |
| SCHEMBL29285845 | 0.78 | CA2 (0.48) | CA2CA4CA5AENPP2KDM4E | |
| Hydrochloric Acid SCHEMBL28914355 | 0.76 | CA2 (0.46) | CA2CA4CA5AENPP2KDM4E | |
| SCHEMBL14204720 | 0.76 | ENPP2 (0.47) | CA2CA4CA5AENPP2KDM4E | |
| SCHEMBL18815955 | 0.75 | CA2 (0.58) | CA2CA4CA5AENPP2CA1 | |
| SCHEMBL204921 | 0.74 | ENPP2 (0.73) | CA2CA4CA5AENPP2KDM4E | |
| SCHEMBL4729714 | 0.73 | ENPP2 (0.48) | CA2CA4CA5AENPP2KDM4E | |
| SCHEMBL22999982 | 0.73 | CA2 (0.60) | CA2CA4CA5ATSHRCA14 | |
| SCHEMBL4953765 | 0.73 | CA2 (0.60) | CA2CA4CA5ATSHRCA14 | |
| Phenylboronic Acid SCHEMBL28454899 | 0.72 | ENPP2 (0.74) | CA2CA4CA5AENPP2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090292135-A1 | ORGANOMETAL BENZENEPHOSPHONATE COUPLING AGENTS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | US | disclosed |
| US-20090292135-A1 | ORGANOMETAL BENZENEPHOSPHONATE COUPLING AGENTS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | US | disclosed |
| US-20090005321-A1 | Phenylazetidinone Derivatives | MICROBIA, INC. (US) | 2009-01-01 | — | — | US | disclosed |
| US-20090005321-A1 | Phenylazetidinone Derivatives | MICROBIA, INC. (US) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090292135-A1 | ORGANOMETAL BENZENEPHOSPHONATE COUPLING AGENTS | ZNF207, TST, BOLA2; BOLA2B | CA2 1980/4885CA4 2221/4885CA5A 2785/4885 |
| US-20090005321-A1 | Phenylazetidinone Derivatives | TYR, AAAS, FANCD2 | CA2 4388/4885CA4 3955/4885CA5A 593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.